Works matching DE "STRUCTURED treatment interruption"

Results: 124
    1
    2
    3
    4

    Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †

    Published in:
    Cancers, 2024, v. 16, n. 11, p. 2108, doi. 10.3390/cancers16112108
    By:
    • Candoni, Anna;
    • Chiusolo, Patrizia;
    • Lazzarotto, Davide;
    • Sartor, Chiara;
    • Dargenio, Michelina;
    • Chiaretti, Sabina;
    • Skert, Cristina;
    • Giglio, Fabio;
    • Trappolini, Silvia;
    • Fracchiolla, Nicola Stefano;
    • Medici, Sara;
    • Bresciani, Paola;
    • Cuoghi, Angela;
    • Papayannidis, Cristina
    Publication type:
    Article
    5
    6

    Drug Holiday in Osteoporosis.

    Published in:
    JK Science, 2024, v. 26, n. 3, p. 137
    By:
    • Mahajan, Annil;
    • Bashir, Sana;
    • Sharma, Sudhaa;
    • Tandon, Vishal R.
    Publication type:
    Article
    7
    8

    Central nervous system medication use around hospitalization.

    Published in:
    Journal of the American Geriatrics Society, 2024, v. 72, n. 6, p. 1707, doi. 10.1111/jgs.18915
    By:
    • Pavon, Juliessa M.;
    • Sloane, Richard J.;
    • Colón‐Emeric, Cathleen S.;
    • Pieper, Carl F.;
    • Schmader, Kenneth;
    • Gallagher, David;
    • Hastings, Susan N.
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Bisphosphonate drug holidays in osteoporosis according to fracture risk profile.

    Published in:
    Osteoporosis International, 2025, v. 36, n. 2, p. 245, doi. 10.1007/s00198-024-07309-9
    By:
    • Salmoral, Asunción;
    • Peris, P.;
    • López Medina, C.;
    • Flórez, H.;
    • Barceló, M.;
    • Pascual Pastor, M.;
    • Ros, I.;
    • Grados, D.;
    • Aguado, P.;
    • García, S.;
    • López, L.;
    • Gifre, L.;
    • Cerdá, D.;
    • Aguilar, F. J.;
    • Panero, B.;
    • Costa, E.;
    • Casado, E.;
    • Hernández, B.;
    • Martínez Ferrer, A.;
    • Graña, J.
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28

    First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data.

    Published in:
    International Journal of Clinical Oncology, 2024, v. 29, n. 4, p. 473, doi. 10.1007/s10147-024-02471-w
    By:
    • Ishihara, Hiroki;
    • Omae, Kenji;
    • Nemoto, Yuki;
    • Ishiyama, Ryo;
    • Tachibana, Hidekazu;
    • Nishimura, Koichi;
    • Ikeda, Takashi;
    • Kobari, Yuki;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Iizuka, Junpei;
    • Kondo, Tsunenori;
    • Takagi, Toshio
    Publication type:
    Article
    29
    30

    Long‐term safety and tolerability of hyaluronidase‐facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE‐CIDP 3 trial.

    Published in:
    Journal of the Peripheral Nervous System, 2024, v. 29, n. 4, p. 441, doi. 10.1111/jns.12672
    By:
    • Hadden, Robert D. M.;
    • Andersen, Henning;
    • Bril, Vera;
    • Basta, Ivana;
    • Rejdak, Konrad;
    • Duff, Kim;
    • Greco, Erin;
    • Hasan, Shabbir;
    • Anderson‐Smits, Colin;
    • Ay, Hakan
    Publication type:
    Article
    31

    Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01271-3
    By:
    • Sawalha, Y.;
    • Sarosiek, S.;
    • Welkie, R. L.;
    • Seif, S.;
    • Thapa, S.;
    • Zanwar, S.;
    • Cahill, K.;
    • Treitman, R.;
    • Shah, H.;
    • Arora, S.;
    • Pongas, G.;
    • Winter, A.;
    • Major, A.;
    • Riedell, P. A.;
    • Palomba, M. L.;
    • Kapoor, P.;
    • Grajales-Cruz, A.;
    • Shain, K. H.;
    • Thomas, S. K.;
    • Castillo, J. J.
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39

    Prescription patterns of venetoclax in acute myeloid leukemia.

    Published in:
    Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3298
    By:
    • Ucciero, Andrealuna;
    • Traversa, Giuseppe;
    • Pisterna, Alessia;
    • Cardinali, Valeria;
    • Sciabolacci, Sofia;
    • Poloni, Antonella;
    • Capelli, Debora;
    • Gaidano, Gianluca;
    • Patriarca, Andrea;
    • Lunghi, Monia
    Publication type:
    Article
    40
    41
    42
    43

    Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System.

    Published in:
    Oncology Letters, 2024, v. 27, n. 2, p. N.PAG, doi. 10.3892/ol.2023.14193
    By:
    • Inoue, Yu;
    • Okamoto, Haruya;
    • Miyashita, Akihiro;
    • Kawaji-Kanayama, Yuka;
    • Chinen, Shotaro;
    • Fujino, Takahiro;
    • Tsukamoto, Taku;
    • Shimura, Yuji;
    • Mizutani, Shinsuke;
    • Kaneko, Hiroto;
    • Kuwahara-Ota, Saeko;
    • Fuchida, Shin-Ichi;
    • Nishiyama, Daichi;
    • Hirakawa, Koichi;
    • Uchiyama, Hitoji;
    • Uoshima, Nobuhiko;
    • Kawata, Eri;
    • Kuroda, Junya
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50